Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CLINICAL DATA INC | b81284e10vk.htm |
| EX-23.1 - EX-23.1 - CLINICAL DATA INC | b81284exv23w1.htm |
| EX-31.2 - EX-31.2 - CLINICAL DATA INC | b81284exv31w2.htm |
| EX-21.1 - EX-21.1 - CLINICAL DATA INC | b81284exv21w1.htm |
| EX-31.1 - EX-31.1 - CLINICAL DATA INC | b81284exv31w1.htm |
EXHIBIT 32.1
STATEMENT PURSUANT TO 18 U.S.C. § 1350
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code
(18 U.S.C. §1350), Andrew J. Fromkin, Chief Executive Officer of Clinical Data, Inc. and C. Evan
Ballantyne, Chief Financial Officer of the Company, each hereby certifies that, to the best of his
knowledge:
| (1) | The Company’s Annual Report on Form 10-K for the period ended March 31, 2010, to which this Certification is attached as Exhibit 32.1 (the “Annual Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act; and | ||
| (2) | The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the end of such year. |
| /s/ Andrew J. Fromkin | ||||
| Date: June 14, 2010 | Andrew J. Fromkin | |||
| President and Chief Executive Officer | ||||
| /s/ C. Evan Ballantyne | ||||
| Date: June 14, 2010 | C. Evan Ballantyne | |||
| Executive Vice President and Chief Financial Officer | ||||
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not incorporated by reference into any filing of Clinical
Data, Inc. under the Securities Exchange Act of 1934, as amended (whether made before or after the
date of the Form 10-K), irrespective of any general incorporation language contained in such
filing.